Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia.

Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. Skinmed. 2020;18(4):254-255 Authors: Tiscornia JE, Poggio TV, Feinsilber DG, Coleman AE PMID: 33050993 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33050993?dopt=Abstract

Source: Skinmed - October 20, 2020 Category: Dermatology Authors: Tiscornia JE, Poggio TV, Feinsilber DG, Coleman AE Tags: Skinmed Source Type: research

More News: COVID-19 | Dermatology | Pneumonia